Severe and recurrent episodes of bronchiolitis obliterans organising pneumonia associated with indolent CD4+ CD8+ T-cell leukaemia

European Respiratory Journal

Volumn 31, Issue 6, 2008, Pages 1368-1372

  Martinez Gallo, M ^a   Puy, C ^a   Ruiz Hernandez, R ^b   Rodriguez Arias, J M ^a   Bofill, M ^b   Nomdedeu, J F ^c   Cigudosa, J C ^a   Rodriguez Sanchez, J L ^a   De La Calle Martin, O ^a  

^a HOSPITAL DE LA SANTA CREU I SANT PAU   (Spain)

^b HOSPITAL UNIVERSITARI GERMANS TRIAS I PUJOL   (Spain)

^c Centro Nacional de Investigaciones Oncológicas   (Spain)

Author keywords

Bronchiolitis obliterans and organising pneumonia; CC chemokine receptor 6; CD103; Double positive T cells; Indolent T prolymphocytic leukaemia; Interstitial lung disease

Indexed keywords

AZATHIOPRINE; CYCLOSPORIN A; PREDNISONE; T LYMPHOCYTE RECEPTOR BETA CHAIN; ANTIINFLAMMATORY AGENT; PREDNISOLONE;

ACUTE RESPIRATORY FAILURE; ADULT; ANEMIA; ARTICLE; ATAXIA TELANGIECTASIA; BRONCHIOLITIS OBLITERANS ORGANIZING PNEUMONIA; CASE REPORT; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; DISEASE ASSOCIATION; DISEASE SEVERITY; HUMAN; HUMAN TISSUE; LOW DRUG DOSE; LUNG BIOPSY; LUNG LAVAGE; LYMPHOCYTIC INFILTRATION; MALE; MONOTHERAPY; PRIORITY JOURNAL; PROLYMPHOCYTIC LEUKEMIA; RECURRENT DISEASE; T CELL LEUKEMIA; BLOOD; CLASSIFICATION; CYTOLOGY;

ADULT; ANTI-INFLAMMATORY AGENTS; BRONCHIOLITIS OBLITERANS ORGANIZING PNEUMONIA; BRONCHOALVEOLAR LAVAGE FLUID; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; HUMANS; LEUKEMIA, T-CELL; MALE; PREDNISOLONE;

EID: 49649095414     PISSN: 09031936     EISSN: 13993003     Source Type: Journal    
DOI: 10.1183/09031936.00061907     Document Type: Article

References (11)

1. Ryu JH, Myers JL, Swenson SJ. Bronchiolar disorders. Am J Respir Crit Care Med 2003; 168: 1277-1292.
2. Parel Y, Chizzolini C. CD4+ CD8+ double positive (DP) T cells in health and disease. Autoimmun Rev 2004; 3: 215-220.
3. Herling M, Khoury JD, Washington LT, Duvic M, Keating MJ, Jones D. A systematic approach to diagnosis of mature T-cell leukemias reveals heterogeneity among WHO categories. Blood 2004; 104: 328-335.
4. Roca J, Sanchis J, Agusti-Vidal A, et al. Spirometric reference values from a Mediterranean population. Bull Eur Physiopathol Respir 1986; 22: 217-224.
5. Plastiras SC, Soliotis FC, Vlachoyiannopoulos P, Tzelepis GE. Interstitial lung disease in a patient with antisynthetase syndrome and no myositis. Clin Rheumatol 2007; 26: 108-111.
6. Roy M, Waldschmidt T, Aruffo A, Ledbetter JA, Noelle RJ. The regulation of the expression of gp39, the CD40 ligand, on normal and cloned CD4+ T cells. J Immunol 1993; 151: 2497-2510.
7. Kay NE, Bone N, Huple M, Dalmasso AP. Expansion of a lymphocyte population co-expressing T4 (CD4) and T8 (CD8) antigens in the peripheral blood of a normal adult male. Blood 1990; 75: 2024-2029.
8. Dearden CE. T-cell prolymphocytic leukemia. Med Oncol 2006; 23: 17-22.
9. Chun HH, Castellví-Bel S, Wang Z, et al. TCL-1, MTCP-1 and TML-1 gene expression profile in non-leukemic clonal proliferations associated with ataxia-telangiectasia. Int J Cancer 2002; 97: 726-731.
10. Taylor AM, Mefcalfe JA, Thick J, Mak YF. Leukemia and lymphoma in ataxia telangiectasia. Blood 1996; 87: 423-438.
11. Liao F, Rabin RL, Smith CS, et al. CC-chemokine receptor 6 is expressed on diverse memory subsets of T cells and determines responsiveness to macrophage inflammatory protein 3α. J Immunol 1999; 162: 186-194.